Search
CTR-107
go.drugbank.com/drugs/DB18583ExperimentalCTR-107 is a synthetic targeted growth factor. It is being investigated for the treatment of familial exudative vitreoretinopathy.
Maytansine
go.drugbank.com/drugs/DB19582InvestigationalMaytansine is a small molecule drug. Maytansine is under investigation in clinical trial NCT04189211 (A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients).
RD06-04
go.drugbank.com/drugs/DB24647InvestigationalRD06-04 is under investigation in clinical trial NCT06986018 (Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV). … RD06-04 is a biologic drug.
OTX-2002
go.drugbank.com/drugs/DB17246InvestigationalOTX-2002 is a bicistronic messenger ribonucleic acid (mRNA) encoding for ZF-DNMT and ZF-KRAB proteins, encapsulated in a lipid nanoparticle (LNP).
BNT111
go.drugbank.com/drugs/DB18177InvestigationalBNT111 is an investigational cancer immunotherapy under development for advanced melanoma. It consists of a fixed combination of mRNA-encoded, tumor-associated antigens.
Zansecimab
go.drugbank.com/drugs/DB16389InvestigationalZansecimab is under investigation in clinical trial NCT04342897 (A Study of LY3127804 in Participants With COVID-19).
Categories: Experimental Unapproved Treatments for COVID-19Iferanserin
go.drugbank.com/drugs/DB11686InvestigationalIferanserin has been investigated for the treatment of Hemorrhoids.
Artefenomel
go.drugbank.com/drugs/DB11809InvestigationalArtefenomel has been investigated for the treatment of Malaria.
Lupeol
go.drugbank.com/drugs/DB12622InvestigationalLupeol has been investigated for the treatment of Acne.
Oxomemazine
go.drugbank.com/drugs/DB13820InvestigationalOxomemazine is a phenothiazine derivative.
Categories: Antihistamines for Systemic Use